000			03375nam a22003975i 4500
001			85251
003			ES-MaUEC
005			20230207040502.0
007			cr nn 008mamaa
008			160201s2016 gw | s |||| 0|eng d
020			_a9783319268576
040			_aES-MaUEC
050		4	_aRC268.57 _b2016 EB
082	0	4	_a616.15
245	1	0	_aHIV-associated Hematological Malignancies _cedited by Marcus Hentrich, Stefan K Barta
250			_a1st ed.
260			_aCham _bSpringer International Publishing _c2016
300			_a1 recurso en línea (XII, 237 páginas) _b34 ilustraciones, 3 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aPathology -- Epidemiology -- Non-Hodgkin Lymphoma.-Hodgkin lymphoma -- Acute Myeloid Leukemia (AML) & Myelodysplastic Syndrome (MDS) -- Acute lymphoblastic leukemia (ALL) -- Autologous stem cell transplantation -- Allogeneic stem cell transplantation -- Multiple myeloma and monoclonal gammopathy of unknown significance -- Myeloproliferative disorders -- Multicentric Castelman�s disease -- Chemotherapy and interactions with combination antiretroviral therapy (cART) -- Special considerations.
520	3		_aThis book presents a general introduction to and review of HIV-associated hematological malignancies, with a special focus on practical management issues. Each of the relevant malignancies is addressed individually, with an overview of treatment approaches, assessment of evidence regarding their efficacy, and discussion of therapeutic controversies. In addition, careful consideration is paid to issues in molecular and clinical pathology, epidemiological aspects, symptomatology, diagnosis, and risk factors. Separate chapters are devoted to autologous and allogeneic stem cell transplantation and to chemotherapy and interactions with antiretroviral agents. Many of the chapters are written by experts who have been instrumental in shifting the balance for people living with HIV and blood cancers. While two decades ago this diagnosis represented a death sentence, advances in treatment have transformed these cancers into often curable conditions. Nevertheless, optimal treatment of hematological malignancies remains a challenge, particularly in patients with severe immunosuppression. This book will be an invaluable source of information for all practitioners in the fields of clinical hematology and medical oncology and HIV medicine.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		7	_aMedicina _0comprobar BNE19900959047 _2embne _9405021
650		7	_9140122 _aHematología _0comprobar BNE19900981064 _2embne
700	1		_aHentrich, Marcus _eeditor literario _0Local _998063
700	1		_aBarta, Stefan K. _eeditor literario _998064 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-26857-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9783319268576
907			_a.b12945298 _b10-10-17 _c21-11-16
988			_aSpringer_Medicine_2016
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0
945			_aRC268.57 H583 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11589206 _z06-04-17
999			_c85251 _d85251 _x1